Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 2,850 $ 3,064
Restricted cash 250 250
Accounts receivable, net of allowance for doubtful accounts of $72 and $72, respectively 7,241 6,158
Other current assets 2,777 2,694
Total current assets 13,118 12,166
Property and equipment, net 6,145 6,349
Other intangible assets, net 6,751 7,287
Goodwill 8,433 8,433
Operating lease right of use assets 3,760 4,032
Other long-term assets 151 160
Total assets 38,358 38,427
Current liabilities:    
Accounts payable 3,951 2,694
Accrued salary and bonus 3,461 3,024
Other accrued expenses 8,692 9,198
Current liabilities from discontinued operations 766 766
Total current liabilities 16,870 15,682
Contingent consideration 1,345 1,383
Operating lease liabilities, net of current portion 2,928 3,154
Line of credit 2,500 1,500
Note payable at fair value 7,835 7,942
Other long-term liabilities 4,685 4,648
Total liabilities 36,163 34,309
Commitments and contingencies (Note 8)
Preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,272,308 and 4,228,169 shares issued, respectively; 4,226,422 and 4,195,412 shares outstanding, respectively 404 403
Additional paid-in capital 186,489 186,106
Accumulated deficit (229,306) (227,059)
Treasury stock, at cost (45,886 and 32,757 shares, respectively) (1,928) (1,868)
Total stockholders’ deficit (44,341) (42,418)
Total liabilities and stockholders’ deficit (8,178) (8,109)
Total liabilities, preferred stock and stockholders’ deficit $ 38,358 $ 38,427